Viewing Study NCT04525456


Ignite Creation Date: 2025-12-24 @ 11:24 PM
Ignite Modification Date: 2025-12-31 @ 1:20 PM
Study NCT ID: NCT04525456
Status: COMPLETED
Last Update Posted: 2022-05-27
First Post: 2020-06-29
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Immune Responses With Reduxium
Sponsor: Ogevity Therapeutics, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-10-07
Start Date Type: ACTUAL
Primary Completion Date: 2020-12-15
Primary Completion Date Type: ACTUAL
Completion Date: 2021-01-27
Completion Date Type: ACTUAL
First Submit Date: 2020-06-29
First Submit QC Date: None
Study First Post Date: 2020-08-25
Study First Post Date Type: ACTUAL
Results First Submit Date: 2022-02-28
Results First Submit QC Date: None
Results First Post Date: 2022-05-27
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-05-26
Last Update Post Date: 2022-05-27
Last Update Post Date Type: ACTUAL